COMMUNIQUÉS West-GlobeNewswire

Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares

25/07/2018 - 22:01

DUBLIN, Ireland and KING OF PRUSSIA, Pa., July 25, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV) today announced that it has commenced an underwritten public offering of $50.0 million of ordinary [...]

Savara Provides Positive Update on Development and Commercial Preparations of Molgradex, Including Expansion into NTM In CF

25/07/2018 - 22:01

Acquires assets of Cardeas and Announces Appointment of A. Bruce Montgomery, M.D., As Strategic Advisor AUSTIN, Texas, July 25, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq:SVRA), an orphan lung disease company, today [...]

Align Technology Expands Operations in Costa Rica With New Facilities to Support Continued Long-Term Growth

25/07/2018 - 22:00

Grand Opening Celebration Attended by Costa Rican President Carlos Alvarado Quesada SAN JOSE, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN), announced today that it hosted a grand [...]

Align Technology Announces Second Quarter 2018 Financial Results

25/07/2018 - 22:00

Q2 revenues up 37.5% year-over-year to a record $490.3 million, and diluted EPS of $1.30 Q2 operating income up 46.8% year-over-year to $122.7 million, operating margin of 25.0% Q2 total Invisalign case shipments up 30. [...]

Correction: Rubicon Organics Capitalizes on the Organic Movement -- CFN Media

25/07/2018 - 20:35

In a release dated June 17, 2018, it was mistakenly stated that Rubicon Organics has operations in Washington and Colorado; instead, Rubicon Organics has operations in Washington and California. The corrected release [...]

SHARECARE AND ATLANTA HAWKS HONORED WITH 2017-18 NBA PARTNERSHIP OF THE YEAR AWARD

25/07/2018 - 19:14

THE SHARECARE MOVEMENT , INCLUDING SHARECARE PATCH ON JERSEYS, UNIQUE HEALTH AND WELLNESS CONTENT AND COMMUNITY ENGAGEMENT, RECEIVES LEAGUE’S HIGHEST RECOGNITION ATLANTA, July 25, 2018 (GLOBE NEWSWIRE) -- Sharecare and [...]

Qu Biologics enrolls the first patient in new Phase 2 Crohn’s Disease clinical trial

25/07/2018 - 18:53

VANCOUVER, British Columbia, July 25, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore [...]

Shire plc : Director Declaration

25/07/2018 - 16:31

Director Declaration July 25, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that Steven Gillis, Non-Executive Director of the Company, is a Non-Executive Director of Homology Medicines, Inc., which [...]

Corium Presents Additional Positive Clinical Results at Alzheimer's Association International Conference® 2018

25/07/2018 - 16:30

Pharmacodynamic Results Further Support Therapeutic Equivalence of Corplex™ Donepezil to Aricept® MENLO PARK, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage [...]

Eisai and Biogen Present Detailed Results From Phase II Clinical Study of Elenbecestat in MCI and Mild to Moderate Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2018

25/07/2018 - 16:30

TOKYO and CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq:BIIB) (Headquarters: Cambridge, Massachusetts, United States, CEO: [...]

Immuron Reports Record Revenue Exceeding AU$2 million for the FY18 year

25/07/2018 - 16:00

Key Highlights: Global Immuron Ltd sales revenue reached an AU$2million milestone continuing its upward trend and enjoying a 29% sales increase compared to FY17. US Travelan® sales continue to exceed expectations [...]

BioRestorative Therapies Appoints Jason M. Lipetz, M.D. to its Scientific Advisory Board

25/07/2018 - 15:45

MELVILLE, N.Y., July 25, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today announced that Jason M [...]

TGOD Spin Off Provides Cannabis Investors with Ground Floor Opportunity -- CFN Media

25/07/2018 - 15:30

SEATTLE, July 25, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]

Lexington Biosciences Receives HeartSentry USPTO Patent Approval

25/07/2018 - 15:00

--Patent encompasses functional claims, underlying science and methods VANCOUVER, British Columbia, July 25, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a [...]

Food & Tobacco Veteran Takes the Reins at Tree of Knowledge -- CFN Media

25/07/2018 - 15:00

SEATTLE, July 25, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]

MEDIFIRST SOLUTIONS ANNOUNCES COMPANY UPDATE

25/07/2018 - 15:00

Freehold, NJ , July 25, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology and specialty pharmacy drug and management consulting [...]

RespireRx Pharmaceuticals Inc. Announces Publication of Ampakine Data:

25/07/2018 - 15:00

Effects of Chronic Systemic Low-impact Ampakine Treatment on Neurotrophin Expression in Rat Brain Glen Rock, N.J., July 25, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “ [...]

Anavex Life Sciences Presents New Data Identifying Treatment Response Biomarkers in Alzheimer’s Disease Patients Treated with Investigational ANAVEX®2-73 at 2018 Alzheimer’s Association International Conference (AAIC)

25/07/2018 - 15:00

An Analysis of More Than 33,000 Genes Identified Variants That May Enable a Precision Medicine Approach to Alzheimer’s Disease Research and Treatment The Study Identified 80 Percent of Participants as ANAVEX®2-73 [...]

PolarityTE, Inc. Provides Commercial Update

25/07/2018 - 15:00

SALT LAKE CITY, July 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company, today announced an update on the Company’s commercial progress. [...]